Details for New Drug Application (NDA): 087818
✉ Email this page to a colleague
NDA 087818 describes SULTEN-10, which is a drug marketed by Bausch And Lomb and is included in one NDA. Additional details are available on the SULTEN-10 profile page.
The generic ingredient in SULTEN-10 is sulfacetamide sodium. There are three drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the sulfacetamide sodium profile page.
The generic ingredient in SULTEN-10 is sulfacetamide sodium. There are three drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the sulfacetamide sodium profile page.
Summary for 087818
| Tradename: | SULTEN-10 |
| Applicant: | Bausch And Lomb |
| Ingredient: | sulfacetamide sodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 087818
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 10% | ||||
| Approval Date: | Feb 3, 1983 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
